about
Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug LoadingNanodelivery Systems as New Tools for Immunostimulant or Vaccine Administration: Targeting the Fish Immune SystemComputational Intelligence Modeling of the Macromolecules Release from PLGA Microspheres-Focus on Feature SelectionFe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis.Perspective highlights on biodegradable polymeric nanosystems for targeted therapy of solid tumorsExtended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro releaseA tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinomaNanoparticles and nanofibers for topical drug delivery.A biodegradable killer microparticle to selectively deplete antigen-specific T cells in vitro and in vivo.Enhanced oral bioavailability of acetylpuerarin by poly(lactide-co-glycolide) nanoparticles optimized using uniform design combined with response surface methodology.Proof-of-Concept Studies for Marker-Based Ultrasound Doppler Analysis of Microvascular Anastomoses in a Modified Large Animal Model.Drug-Loaded Polymeric Nanoparticles for Cancer Stem Cell Targeting.Electrospun PLGA Nanofiber Scaffolds Release Ibuprofen Faster and Degrade Slower After In Vivo Implantation.Three-dimensional Printing and 3D Slicer: Powerful Tools in Understanding and Treating Structural Lung Disease.Cardiovascular Bio-Engineering: Current State of the Art.The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatmentThe tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice.PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer's disease mice.Enhanced antitumor efficacy of poly(D,L-lactide-co-glycolide)-based methotrexate-loaded implants on sarcoma 180 tumor-bearing mice.Folic acid conjugation improves the bioavailability and chemosensitizing efficacy of curcumin-encapsulated PLGA-PEG nanoparticles towards paclitaxel chemotherapy.Implantable systems for drug delivery to the brain.Functionalizing PLGA and PLGA Derivatives for Drug Delivery and Tissue Regeneration Applications.[Nanoparticles as drug delivery systems in ophthalmology].Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus.Co-delivery of Doxorubicin Encapsulated PLGA Nanoparticles and Bcl-xL shRNA Using Alkyl-Modified PEI into Breast Cancer Cells.Generation of Well-Defined Micro/Nanoparticles via Advanced Manufacturing Techniques for Therapeutic Delivery.Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile.Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective.Direct modulation of myelin-autoreactive CD4+ and CD8+ T cells in EAE mice by a tolerogenic nanoparticle co-carrying myelin peptide-loaded major histocompatibility complexes, CD47 and multiple regulatory molecules.Paclitaxel-loaded PLA/PEG/fluorescein anticancer agent prepared by Ugi reactionSynergistic Effects of Controlled-Released BMP-2 and VEGF from nHAC/PLGAs Scaffold on OsteogenesisAntimicrobial Activity of 3D-Printed Poly(ε-Caprolactone) (PCL) Composite Scaffolds Presenting Vancomycin-Loaded Polylactic Acid-Glycolic Acid (PLGA) Microspheres
P2860
Q26738335-8F5EAA6D-170A-4224-AB70-396CEF5AF8F3Q26780430-97B4A569-1FA7-481E-81B7-63A76C38936AQ28550344-E1A728EC-C2F5-491B-A95D-E9A5BF054B9BQ30362955-B22554FB-E011-4378-88A2-52508C3B0BCEQ33712145-03433F3C-22A7-4269-90BB-7EBC6516298DQ36395544-C0468304-7688-4E18-9004-98D5E49B30AAQ36848514-9B1C6B59-C87B-4052-A533-134A48799501Q36978587-11259AB1-1F7B-4542-9CD7-A4D8F46131EAQ37022139-FC1B3024-4367-4CD4-9F38-FD98C66E8D48Q37042544-8B5B8A87-B7A1-486D-886D-5DADD8E838BAQ37191064-8B91BB1C-4897-4F92-9488-203EEBC2BF17Q37639772-3E582BE1-F004-42B2-8053-291DD557838DQ38707717-F5FE34AA-91B9-472F-80AF-ED80D20EC989Q38774641-3CBB9A6F-1CE4-4400-AB47-2EC4253EEA78Q39165018-4B28F9DE-CCC3-45C1-8680-A63554E7E22BQ39227810-F198A77A-4DC7-4510-B7E7-1BBB0D47AF45Q41714080-A17187D8-C586-4E05-924D-39705E3C89F2Q42370730-8F471FC8-DD43-45E8-87AB-FD7BD91840BEQ43980757-8A5EA441-A6F0-488E-8E2B-B81E9C0C6D96Q44723040-77DCAE0C-5F12-4641-836B-F6B725A20A83Q47106467-CDC13C1B-F3DF-4775-975C-8465DD2DA683Q47975817-87EED605-8D20-454F-A132-EFA846865BF5Q48240255-FCE135BE-DF2C-43A0-AB61-7FA9B1D9EC44Q50129671-94CE9B75-0E63-4C99-9477-01D684A4E0E6Q50145801-75635647-AD1A-49F3-B073-99668388F641Q51123351-D50BD870-4471-497F-8BD1-6A2DA45F7246Q54994812-94D2840C-5077-4716-95DA-D4182CA77CA1Q55020915-E86DB8C9-560D-42A4-B724-5B0B588341F1Q55035936-12B5C371-67C5-486B-8C9E-0E4898846A8DQ55442040-404D71A5-59EE-4A49-A339-0B080DCE6899Q57370520-0DF880CC-2145-49CA-9507-46CD9F117E66Q57821603-62F5A5BB-A881-483C-8E02-DF8FE07E88A7Q58795247-2CD72088-2FD7-43DF-AFA0-01EAE341DEA3
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
PLGA: a unique polymer for drug delivery.
@en
type
label
PLGA: a unique polymer for drug delivery.
@en
prefLabel
PLGA: a unique polymer for drug delivery.
@en
P2093
P2860
P356
P1433
P1476
PLGA: a unique polymer for drug delivery.
@en
P2093
Amit Bhatia
Gurvinder Kaur
Ripandeep Kaur
Ruchi Sharma
Sanju Dhawan
P2860
P356
10.4155/TDE.14.91
P577
2015-01-01T00:00:00Z